Appointment booking for Dr. Kathryn Wildy, MD is currently not available.Dr. Kathryn Wildy, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Kathryn Wildy, MD (she/her) is a Rheumatologist in Omaha, NE with over 18 years of experience. What is your opinion of Dr. Kathryn Wildy, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Kathryn Wildy, MD has received over $8,946 which includes payments from the following companies:
$1,354.59 from Celgene Corporation
$1,212.97 from Genentech USA, Inc.
$1,211.75 from Amgen Inc.
$929.94 from Pfizer Inc.
$802.44 from AbbVie, Inc.
$679.14 from UCB, Inc.
$540.81 from Janssen Biotech, Inc.
$341.69 from Novartis Pharmaceuticals Corporation
$333.95 from E.R. Squibb & Sons, L.L.C.
$239.38 from GlaxoSmithKline, LLC.
$157.91 from LILLY USA, LLC
$157.04 from Horizon Pharma plc
$156.31 from Regeneron Healthcare Solutions, Inc.
$81.80 from Takeda Pharmaceuticals America, Inc.
$78.14 from Endo Pharmaceuticals Inc.
$73.14 from Antares Pharma, Inc.
$64.86 from Mallinckrodt LLC
$47.62 from MEDAC PHARMA, INC.
$45.07 from Sobi, Inc
$44.70 from Fidia Pharma USA Inc
Payments received by Dr. Kathryn Wildy, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!